Zydus Cadila has received restricted emergency use approval from the DCGI for the use of Pegylated Interferon alpha-2b (PegIFN) in...
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and...
Read moreLonza, a CDMO partner to the biopharma industry, announced the construction of a new small molecule manufacturing complex at its...
Read moreMaxiVAX SA, a private Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine GmbH, a leading contract...
Read moreEvonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines. Commercial...
Read moreEMA approval, millions of AstraZeneca vaccines began shipping on 5 February as part of the initial 17m doses that are...
Read moreBaxter International announced Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19...
Read moreBaxter International announced Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19...
Read moreAurinia Pharmaceuticals Inc. announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build...
Read moreThe road to market for new drugs and pharmaceutical products is long and complicated. Each stage of drug development is...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.